Dr. Belinda Anne Dure-Smith, MD

Dr. Dure-Smith practices at Poway Surgery Center in Poway, California.

Dr. Dure-Smith's NPI, 1487620662, was assigned on February 27, 2006. Dr. Dure-Smith graduated from Warwick Medical School in 1985. Dr. Dure-Smith holds California license A52257.

Dr. Dure-Smith's primary practice is Poway Surgery Center, at 15611 Pomerado Rd, Poway, CA 92064. The practice phone is (858) 521-0031.

Dr. Dure-Smith's primary practice is Poway Surgery Center in Poway, California. Dr. Dure-Smith is also affiliated with Palomar UC San Diego Health Poway. The medical group on file is Palomar Health Medical Group. Dmand AI also links Dr. Dure-Smith to 1 more hospital, 3 home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dure-Smith practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Dure-Smith's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Dure-Smith is licensed in California.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, alcohol use disorders, aneurysm, ankle or foot injury, anxiety and arteritis among the conditions Dr. Dure-Smith treats.

CMS data shows 2,859 Medicare services from Dr. Dure-Smith across 15 procedure codes in 2024, for 414 Medicare patients. Medicare paid $163,387 for them. Every service was in an office.

CMS counts 414 Medicare patients who saw Dr. Dure-Smith in 2024. The largest group is 75 to 84, with 180 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dure-Smith's median patient age at 72, with 79% women.

In 2024, Dr. Dure-Smith wrote 9,255 Medicare Part D claims for 677 patients. 91% of them were for generic drugs. CMS names the drug for 8,471 of them, across 126 drugs with 11 or more claims each, at $543,737 in total drug cost. In 2023, CMS named 9,127 claims across 138 drugs.

Dr. Dure-Smith accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dure-Smith as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Dure-Smith. The most frequent topics are Asia, Fluorides and Osteoporosis. Dr. Dure-Smith's most frequent co-authors are David Baylink, MD, Nosratola D. Vaziri, MD and Madeleine V. Pahl, MD.

CMS Open Payments shows 165 general payments to Dr. Dure-Smith from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $432.

Dmand AI lists 1 award for Dr. Dure-Smith, most recently CMS Stage 1 EHR in 2012.

Dr. Dure-Smith graduated from Warwick Medical School in 1985.

Dr. Dure-Smith is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.